Cytotoxic and Antileishmanial Effects of Various Extracts of Capparis spinosa L.

Objectives: Cutaneous leishmaniasis (CL) is considered as one of the most critical infections worldwide, in which the protozoa of the genus Leishmania infects a person. Today, the common and selective drugs for the treatment of CL are antimonial compounds present some limitations to their usage. The objective of this study is to investigate the cytotoxic and antileishmanial effects of various extracts of Capparis spinosa L. on the in vitro model. Materials and Methods: The primary phytochemical analysis of the C. spinosa extracts was performed to assess the presence of tannins, alkaloids, saponins, flavonoids, terpenoids, and glycosides. Furthermore, the in vitro cytotoxic and antileishmanial effects of C. spinosa extracts on Leishmania tropica promastigote were evaluated. Additionally, these effects on the J774-A1 macrophage cells by colorimetric cell viability 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyl tetrazolium bromide assay were also assessed. Results: In this study, the findings of primary phytochemical screening of the C. spinosa extracts demonstrated the existence of flavonoids, tannins, terpenoids, glycosides, and alkaloids in this plant. Importantly, the findings indicated that the aqueous and methanolic extracts of C. spinosa exhibit a high potency to inhibit the growth of L. tropica promastigotes with inhibitory concentration 50 values of aqueous and methanolic extracts being 28.5 and 44.6 µg/mL, respectively. Based on the obtained results, C. spinosa extracts did not display a considerable cytotoxicity on the J774-A1 macrophage cells. Conclusion: The obtained findings exhibited remarkable antileishmanial effects of C. spinosa extracts on L. tropica, thereby indicating the ability of C. spinosa as a herbal product to be developed as a new antileishmanial drug. Nevertheless, supplementary investigations will be obligatory to achieve these findings, especially in human subjects.

Capparis spinosa L.’nin Farklı Ekstrelerinin Sitotoksik ve Antileishmanial Etkileri

Amaç: Leishmania protozoa türünün insanı enfekte etmesiyle görülen kutanöz leishmania (CL) dünya genelindeki en kritik enfeksiyonlardan biri kabul edilmektedir. Bugün, CL’nin tedavisi için sıklıkla kullanılan ve seçilmiş ilaçlar olan antimonial bileşiklerin kullanımlarında bazı kısıtlamalar vardır. Bu çalışmanın amacı of Capparis spinosa L.’nin farklı ekstrelerinin in vitro modelde sitotoksik ve antileishmanial etkilerinin incelenmesidir. Gereç ve Yöntemler: C. spinosa ekstrelerinin primer fitokimyasal analizi tannen, alkaloid, saponin, flavonoid, terpenoid ve glikosidlerinin değerlendirmek için yapılmıştır. Ayrıca, C. spinosa ekstrelerinin Leishmania tropica promastigotu üzerindeki in vitro sitotoksik ve antileishmanial etkileri değerlendirilmiştir. Ek olarak, bu etkiler kolorimetrik hücre canlılığı 3-(4,5-dimetil-tiyazolil-2,5-)difeniltetrazolyum bromid yöntemiyle J774-A1 makrofaj hücrelerinde de belirlenmiştir. Bulgular: Bu çalışmada, C. spinosa ekstrelerinin primer fiotokimyasal izlemlenmesi bu bitkide tannen, alkaloid, saponin, flavonoid, terpenoid ve glikosidlerinin varlığını göstermiştir. Önemli olarak, bulgular C. spinosa’nın sulu ve metanolik ekstrelerinin sırasıyla 28,5 ve 44,6 µg/mL inhibitor konsantrasyon 50 değerleriyle L. tropica promastigotunun büyümesini yüksek bir potens ile inhibe ettiğini göstermiştir. Elde edilen verilere göre, C. spinosa ekstreleri J774-A1 makrofaj hücrelerinde belirgin bir toksisite göstermemiştir.

Kaynakça

World Health Organization. Control of the Leishmaniasis. Vol. 949. Geneva, Switzerland: WHO; 2010.

Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immun Microbiol Infect Dis. 2004;27:305-318.

Sharifi F, Sharifi I, Zarean M, Parizi MH, Aflatoonian M, Harandi MF, Zahmatkesh R, Mashayekhi M, Kermanizadeh A. Spatial distribution and molecular identification of Leishmania species from endemic foci of South-eastern Iran. Iran J Parasitol. 2012;7:45-52.

Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, Bernardino A, Bourguignon SC, Corte-Real S, Pinho RT, Rodrigues CR, Castro HC. Leishmaniasis treatment-a challenge that remains: a review. Parasitol Res. 2008;103:1-10.

Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19:11-26.

Rasoulian B, Kheirandish F. Herbal medicines: from traditional medicine to modern experimental approaches. Herb Med J. 2017;2:1-2.

Saedi Dezaki E, Mahmoudvand H, Sharififar F, Fallahi S, Monzote L, Ezatkhah F. Chemical composition along with anti-leishmanial and cytotoxic activity of Zataria multiflora. Pharm Biol. 2016;54:752-758.

Nabavi SF, Maggi F, Daglia M, Habtemariam S, Rastrelli L, Nabavi SM. Pharmacological Effects of Capparis spinosa L. Phytother Res. 2016;30:1733-1744.

Mahmoudvand H, Asadi A, Harandi MF, Sharififar F, Jahanbakhsh S, Dezaki ES. In vitro lethal effects of various extracts of Nigella sativa seed on hydatid cyst protoscoleces. Iran J Basic Med Sci. 2014;17:1001- 1006.

Mahmoudvand H, Sharififar F, Rahmat MS, Tavakoli R, Dezaki ES, Jahanbakhsh S, Sharifi I. Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis vulgaris and Nigella sativa against Leishmania tropica. J Vector Borne Dis. 2014;51:294-299.

Mahmoudvand H, Saedi Dezaki E, Sharififar F, Ezatpour B, Jahanbakhsh S, Fasihi Harandi M. Protoscolecidal effect of Berberis vulgaris root extract and its main compound, berberine in cystic echinococcosis. Iran J Parasitol. 2014;9:503-510.

Trease GE, Evans WC. Pharmacognosy. 15th ed. Saunders Publishers, London. 2002:42-44.

Mahmoudvand H, Kheirandish F, Mirbadie SR, Kayedi MH, Rezaei Riabi T, Ghasemi AA, Bamorovat M, Sharifi I. The potential use of methotrexate in the treatment of cutaneous leishmaniasis: in vitro assays against sensitive and meglumine antimoniate-resistant strains of Leishmania tropica. Iran J Parasitol. 2017;12:339-347.

Mahmoudvand H, Shakibaie M, Tavakoli R, Jahanbakhsh S, Sharifi I. In vitro study of leishmanicidal activity of biogenic selenium nanoparticles against Iranian isolate of sensitive and glucan-time-resistant Leishmania tropica. Iranian J Parasitol. 2014;9:452-460.

Mahmoudvand H, Saedi Dezaki E, Ezatpour B, Sharifi I, Kheirandish F, Rashidipour M. In vitro and in vivo antileishmanial activities of Pistacia vera essential oil. Planta Med. 2016;82:279-284.

Kheirandish F, Delfan B, Mahmoudvand H, Moradi N, Ezatpour B, Ebrahimzadeh F, Rashidipour M. Antileishmanial, antioxidant, and cytotoxic activities of Quercus infectoria Olivier extract. Biomed Pharmacother. 2016;82:208-215.

Mahmoudvand H, Ezzatkhah F, Sharififar F, Sharifi I, Dezaki ES. Antileishmanial and cytotoxic effects of essential oil and methanolic extract of Myrtus communis L. Korean J Parasitol. 2015;53:21-27.

Mahmoudvand H, Mirbadie SR, Sadooghian S, Harandi MF, Jahanbakhsh S, Saedi Dezaki E. Chemical composition and scolicidal activity of Zataria multiflora Boiss essential oil. J Essential Oil Res. 2017;29:42- 47.

Mahmoudvand H, Mahmoudvand H, Oliaee RT, Kareshk AT, Mirbadie SR, Aflatoonian MR. In vitro protoscolicidal effects of cinnamomum zeylanicum essential oil and its toxicity in mice. Pharmacogn Mag. 2017;13:S652-S657

Mahmoudvand H, Mirbadie SR, Ghasemi Kia M, Badparva E, Shamsadini Lori S, Fasihi Harandi M. Efficacy of pistacia khinjuk fruits on viability of hydatid cyst protoscoleces and its acute toxicity in mice model. Iran J Parasitol. 2016;11:383-388.

Bahmani B, Saki K, Ezatpour B, Shahsavari S, Eftekhari Z, Jeldori M, Kopaei MR, Sepahvand R. Leishmaniosis phytotherapy: review of plants used in Iranian traditional medicine on leishmaniasis. Asian Pacific J Trop Biomed. 2015;5:695-701.

Tlili N, Elfalleh W, Saadaoui E, Khaldi A, Triki S, Nasri N. The caper (Capparis L.): ethnopharmacology, phytochemical and pharmacological properties. Fitoterapia. 2011;82:93-101.

Antwi CA, Amisigo CM, Adjimani JP, Gwira TM. In vitro activity and mode of action of phenolic compounds on Leishmania donovani. PLoS Negl Trop Dis. 2019;13:e0007206.

Monzote L, Perera Córdova WH, García1 M, Piñón A, Setzer WN. Invitro and In-vivo Activities of Phenolic Compounds Against Cutaneous Leishmaniasis. Rec Nat Prod. 2016;10:269-276.

Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, da Cunha Pinto A, Henriques AT, Bou-Habib DC, Saraiva1 EMB. Antileishmanial Activity of an Indole Alkaloid from Peschiera australis. Antimicrob Agents Chemother. 2001;45:1349-1354.

Tasdemir D, Kaiser M, Brun R, Yardley V, Schmidt TJ, Tosun F, Rüedi P. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother. 2006;50:1352-1364.

Arruda DC, D’Alexandri FL, Katzin AM, Uliana SR. Antileishmanial activity of the terpene nerolidol. Antimicrob Agents Chemother. 2005;49:1679-1687.

Lucchini JJ, Corre J, Cremieux A. Antibacterial activity of phenolic compounds and aromatic alcohols. Res Microbiol. 1990;141:499-510.

Tavakoli Kareshk A, Keyhani A, Mahmoudvand H, Tavakoli Oliaei R, Asadi A, Andishmand M, Azzizian H, Babaei Z, Zia-Ali N. Efficacy of the Bunium persicum (Boiss) essential oil against acute toxoplasmosis in mice model. Iran J Parasitol. 2015;10:625-631.

Mahmoudvand H, Tavakoli Oliaei R, Mirbadie SR, Kheirandish F, Tavakoli Kareshk A, Ezatpour B, Mahmoudvand H. Efficacy and safety of bunium persicum (Boiss) to inactivate protoscoleces during hydatid cyst operations. Surg Infect (Larchmt). 2016;17:713-719.

Niazi M, Saki M, Sepahvand M, Jahanbakhsh S, Khatami M, Beyranvand M. In vitro and ex vivo scolicidal effects of Olea europaea L. to inactivate the protoscolecs during hydatid cyst surgery. Ann Med Surg (Lond). 2019;42:7-10.

Puupponen-Pimiä R, Nohynek L, Meier C, Kähkönen M, Heinonen M, Hopia A, Oksman-Caldentey KM. Antimicrobial properties of phenolic compounds from berries. J Appl Microbiol. 2001;90:494-507.

Kar N, Ghosh S, Kumari L, Chakraborty S, Bera T. Search for new antileishmanial chemotherapeutics. Inter J Pharm Pharm Sci. 2018;10:46-52.

Kaur R, Kaur J, Kaur S, Joshi J. Evaluation of the antileishmanial efficacy of medicinal plant Chenopodium album Linn. against experimental visceral leishmaniasis. Inter J Pharm Pharm Sci. 2016;7:227-231.

Weninger B, Robledo S, Arango GJ, Deharo E, Arango R, Munoz V, Callapa J, Lobstein A, Anton R. Antiprotozoal activities of Colombian plants. J Ethnopharmacol. 2001;78:193-200.

Ezatpour B, Saedi Dezaki E, Mahmoudvand H, Azadpour M, Ezzatkhah F. In vitro and in vivo antileishmanial effects of Pistacia khinjuk against Leishmania tropica and Leishmania major. Evid Based Complement Alternat Med. 2015;2015:149707.

Kaynak Göster